Search Count: 17
 |
Crystal Structure Of Bace1 In Complex With N-{3-[(5R)-3-Amino-2,5-Dimethyl-1,1-Dioxo-5,6-Dihydro-2H-1Lambda6,2,4-Thiadiazin-5-Yl]-4-Fluorophenyl}-5-Fluoropyridine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2021-03-31 Classification: HYDROLASE Ligands: IOD, GOL, 66F |
 |
Crystal Structure Of Bace1 In Complex With N-{3-[(4R)-2-Amino-4-(Prop-1-Yn-1-Yl)-5,6-Dihydro-4H-1,3-Oxazin-4-Yl]-4-Fluorophenyl}-5-Cyanopyridine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2021-03-31 Classification: HYDROLASE Ligands: IOD, GOL, GTU |
 |
Crystal Structure Of Bace1 In Complex With N-{3-[(9S)-7-Amino-2,2-Difluoro-9-(Prop-1-Yn-1-Yl)-6-Oxa-8-Azaspiro[3.5]Non-7-En-9-Yl]-4-Fluorophenyl}-5-Cyanopyridine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2021-03-31 Classification: HYDROLASE Ligands: IOD, GOL, GX6 |
 |
Bace2 Xaperone Complex With N-{3-[(5R)-3-Amino-2,5-Dimethyl-1,1-Dioxo-5,6-Dihydro-2H-1Lambda6,2,4-Thiadiazin-5-Yl]-4-Fluorophenyl}-5-Fluoropyridine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.31 Å Release Date: 2021-03-31 Classification: HYDROLASE/IMMUNE SYSTEM Ligands: 66F, CL, EDO, NA |
 |
Bace2 Xaperone Complex With N-{3-[(9S)-7-Amino-2,2-Difluoro-9-(Prop-1-Yn-1-Yl)-6-Oxa-8-Azaspiro[3.5]Non-7-En-9-Yl]-4-Fluorophenyl}-5-Cyanopyridine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.04 Å Release Date: 2021-03-31 Classification: HYDROLASE/IMMUNE SYSTEM Ligands: GX6 |
 |
Crystal Structure Of Bace1 In Complex With N-{3-[(4R,5R,6R)-2-Amino-5-Fluoro-4,6-Dimethyl-5,6-Dihydro-4H-1,3-Thiazin-4-Yl]-4-Fluorophenyl}-5-(Fluoromethoxy)Pyrazine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2019-10-30 Classification: HYDROLASE Ligands: IOD, GOL, DMS, C83 |
 |
Crystal Structure Of Bace1 In Complex With N-(3-((4S,5R)-2-Amino-4-Methyl-5-Phenyl-5,6-Dihydro-4H-1,3-Thiazin-4-Yl)-4-Fluorophenyl)-5-(Fluoromethoxy)Pyrazine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2019-08-28 Classification: HYDROLASE Ligands: IOD, DMS, C6R |
 |
Crystal Structure Of Bace1 In Complex With N-(3-((4S,5S)-2-Amino-4-Methyl-5-Phenyl-5,6-Dihydro-4H-1,3-Thiazin-4-Yl)-4-Fluorophenyl)-5-(Fluoromethoxy)Pyrazine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2019-08-28 Classification: HYDROLASE Ligands: IOD, DMS, C7X |
 |
Crystal Structure Of Bace1 In Complex With N-{3-[(4S)-2-Amino-4-Methyl-5,6-Dihydro-4H-1,3-Thiazin-4-Yl]-4-Fluorophenyl}-5-Chloropyridine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2019-08-28 Classification: HYDROLASE Ligands: IOD, NA, GOL, C6U |
 |
Crystal Structure Of Bace1 In Complex With N-{3-[(5R)-3-Amino-5-Methyl-9,9-Dioxo-2,9Lambda6-Dithia-4-Azaspiro[5.5]Undec-3-En-5-Yl]-4-Fluorophenyl}-5-(Fluoromethoxy)Pyrazine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2019-08-28 Classification: HYDROLASE Ligands: IOD, GOL, C7O |
 |
Bace2 Xaperone Complex With N-{3-[(5R)-3-Amino-5-Methyl-9,9-Dioxo-2,9Lambda6-Dithia-4-Azaspiro[5.5]Undec-3-En-5-Yl]-4-Fluorophenyl}-5-(Fluoromethoxy)Pyrazine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.53 Å Release Date: 2019-08-28 Classification: HYDROLASE/IMMUNE SYSTEM Ligands: C7O, CL |
 |
Structure Of Bace1 In Complex With N-(3-((4R,5R,6S)-2-Amino-6-(1,1-Difluoroethyl)-5-Fluoro-4-Methyl-5,6-Dihydro-4H-1,3-Oxazin-4-Yl)-4-Fluorophenyl)-5-(Fluoromethoxy)Pyrazine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2018-08-08 Classification: HYDROLASE/INHIBITOR Ligands: IOD, GOL, DMS, 0B5 |
 |
Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 6-((3-(Cyanomethoxy)-4-(1-Methyl-1H-Pyrazol-4-Yl)Phenyl)Amino)-2-(Cyclohexylamino)Nicotinonitrile
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2015-04-08 Classification: TRANSFERASE Ligands: IOD, O38 |
 |
Crystal Structure Of Human Mps1 Catalytic Domain In Complex With (E)-3-(4-((6-(((3S,5S,7S)-Adamantan-1-Yl)Amino)-4-Amino-5-Cyanopyridin-2-Yl)Amino)-2-(Cyanomethoxy)Phenyl)-N-(2-Methoxyethyl)Acrylamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.05 Å Release Date: 2015-04-08 Classification: TRANSFERASE Ligands: O17 |
 |
Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4-(6-(Cyclohexylamino)-8-(((Tetrahydro-2H-Pyran-4-Yl)Methyl)Amino)Imidazo[1,2-B]Pyridazin-3-Yl)-N-Cyclopropylbenzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2015-02-11 Classification: TRANSFERASE Ligands: O43 |
 |
Crystal Structure Of Human Mps1 Catalytic Domain In Complex With N-Cyclopropyl-4-(8-((Thiophen-2-Ylmethyl)Amino)Imidazo[1,2-A]Pyrazin-3-Yl)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2015-02-11 Classification: TRANSFERASE Ligands: CL, O23 |
 |
Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4-[(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)Amino]Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2012-06-27 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: IOD, O22 |